Physiomics plc Company Profile

16:01 EDT 23rd June 2018 | BioPortfolio

Physiomics develops world class computational systems biology models to predict and understand cancer drug efficacy from pre-clinical research to clinical development


The Magdalen CentreOxford Science Park
United Kingdom


Phone: 44 (0) 1865 784980

News Articles [10 Associated News Articles listed on BioPortfolio]

Physiomics narrows losses despite sliding revenues

Computational biology services provider Physiomics saw revenue drop 57% to £74,000 over the six months leading to 31 December, but the Oxford-based firm believed that a resurgence of interest in ra.....

Physiomics ready to build on Merck Serono landmark

Physiomics' share price surged on a €500,000 contract for its virtual tumour software with Merck KgaA.

Physiomics PLC: Personalised medicines will build on momentum from recent pharma deals

Jim MIllen, Physiomics Plc's chief executive, explains how the trend towards personalised medicines will aid the commercialisation of its virtual tumour software. UK development agency Innovate ha...

Physiomics wins major new pharma client

Technology-based cancer treatment solutions provider Physiomics announced on Friday that it has been awarded a contract by an unnamed new major pharmaceutical client. The AIM-traded company said th...

Physiomics lands pre-clinical contract for virtual tumour tech

Physiomics' Virtual Tumour is a sophisticated computer model that simulates tumour cell division

Physiomics shares jump as new 'virtual tumour' contract signed

Shares are on the rise in cancer technology company Physiomics after it announced a contract with a major global top 10 pharmaceutical client. The company's shares rose 10% to 7.98p by mid-afternoo...

Physiomics completes Innovate UK oesophageal cancer project

Cancer treatment prediction technology provider Physiomics has successfully completed the Innovate UK grant project announced in January last year, it announced on Monday. The AIM-traded company sa...

Physiomics and Merck team up to progress Virtual Tumour technology

This is a significant milestone for the company as it will generate long-term revenues with management expecting income of £500,000 to be realised in the first 12 months.

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [1 Associated Companies listed on BioPortfolio]

Physiomics plc

Physiomics develops world class computational systems biology models to predict and understand cancer drug efficacy from pre-clinical research to clinical development

More Information about "Physiomics plc" on BioPortfolio

We have published hundreds of Physiomics plc news stories on BioPortfolio along with dozens of Physiomics plc Clinical Trials and PubMed Articles about Physiomics plc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Physiomics plc Companies in our database. You can also find out about relevant Physiomics plc Drugs and Medications on this site too.

Quick Search


Relevant Topics

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Corporate Database Quicklinks

Searches Linking to this Company Record